Camargo Pharmaceutical Services will launch its new brand at the Generic Pharmaceutical Association (GPhA) Annual Meeting. The new brand relates to the company’s 505(b)(2) approval pathway for companies looking to reposition existing products or expand portfolios with differentiated products. “The number of 505(b)(2) approvals has increased steadily in the past few years, and is more relevant than ever given current market constraints, such as the generics cliff,” said Ken Phelps, president and...